Journal for ImmunoTherapy of Cancer (Apr 2019)
Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
- Daniel H. Johnson,
- Chrystia M. Zobniw,
- Van A. Trinh,
- Junsheng Ma,
- Roland L. Bassett Jr,
- Noha Abdel-Wahab,
- Jaime Anderson,
- Jennifer E. Davis,
- Jocelyn Joseph,
- Marc Uemura,
- Ali Noman,
- Hamzah Abu-Sbeih,
- Cassian Yee,
- Rodabe Amaria,
- Sapna Patel,
- Hussein Tawbi,
- Isabella C. Glitza,
- Michael A. Davies,
- Michael K. Wong,
- Scott Woodman,
- Wen-Jen Hwu,
- Patrick Hwu,
- Yinghong Wang,
- Adi Diab
Affiliations
- Daniel H. Johnson
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Chrystia M. Zobniw
- Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center
- Van A. Trinh
- Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center
- Junsheng Ma
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center
- Roland L. Bassett Jr
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center
- Noha Abdel-Wahab
- Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center
- Jaime Anderson
- Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center
- Jennifer E. Davis
- Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center
- Jocelyn Joseph
- Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center
- Marc Uemura
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Ali Noman
- Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center
- Hamzah Abu-Sbeih
- Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center
- Cassian Yee
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Rodabe Amaria
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Sapna Patel
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Hussein Tawbi
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Isabella C. Glitza
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Michael A. Davies
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Michael K. Wong
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Scott Woodman
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Wen-Jen Hwu
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Patrick Hwu
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- Yinghong Wang
- Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center
- Adi Diab
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1186/s40425-018-0469-9
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 1
Abstract
Following publication of the original article [1], the authors reported an error in their listed affiliations.
